CD8+ tumor-specific Tc cells primed in vivo or in vitro against the BALB/c plasmacytoma ADJ-PC-5 use the same TcR V beta families but display distinct TC1 or TC2 characteristics.
暂无分享,去创建一个
[1] C. Becker,et al. Suppression of Tumour‐Specific Cytotoxic T‐Cell Responses Against the Syngeneic BALB/c Plasmacytoma ADJ‐PC‐5 by Tumour‐Induced CD8+ Regulatory T Cells Via IFN‐γ , 1996, Scandinavian journal of immunology.
[2] M. Ruzek,et al. Specific decrease of Th1-like activity in mice with plasma cell tumors. , 1995, International immunology.
[3] T. Mosmann,et al. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. , 1995, Immunity.
[4] D. Alarcón-Segovia,et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.
[5] F. Erard,et al. Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functions. , 1994, Current opinion in immunology.
[6] B. Sander,et al. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. , 1993, Journal of immunological methods.
[7] C. Heusser,et al. Detection of intracellular cytokines by flow cytometry. , 1993, Journal of immunological methods.
[8] P. Linsley,et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 , 1992, Cell.
[9] P. Altevogt,et al. Murine Fcγ receptor proteins: identification of a previously unrecognized molecule with a monoclonal antibody (12‐15) , 1988 .
[10] W. Paul,et al. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1 , 1985, Nature.
[11] F. Takei. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). , 1985, Journal of immunology.
[12] H. Waldmann,et al. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.
[13] P. Brouckaert,et al. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase–dependent manner , 2009, The Journal of experimental medicine.
[14] D. Sachs,et al. Serologic cross-reactivity between Class I MHC molecules and an H-2- linked differentiation antigen as detected by monoclonal antibodies , 1984, The Journal of experimental medicine.
[15] M. Loken,et al. Flow cytometry as an analytical and preparative tool in immunology. , 1982, Journal of immunological methods.
[16] K. Ozato,et al. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. , 1980, Journal of immunology.
[17] G. Galfré,et al. Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody , 1979, European journal of immunology.
[18] J. Haimovich,et al. Cell surface immunoglobulins of murine plasma cell tumors , 1977 .
[19] V. Schirrmacher,et al. Correlation of “sneaking through” of tumor cells with specific immunological impairment of the host , 1975, European journal of immunology.
[20] L. Old,et al. ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS * , 1962 .
[21] D. Sulitzeanu. Immunosuppressive factors in human cancer. , 1993, Advances in cancer research.
[22] Walter F. Bodmer,et al. MHC antigens and cancer: implications for T-cell surveillance. , 1992 .
[23] R. Fernandez-Botran,et al. Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes. , 1988, The Journal of molecular and cellular immunology : JMCI.
[24] P. Marrack,et al. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. , 1986, Advances in immunology.
[25] R. Zinkernagel,et al. Cytotoxic T cell clone‐specific monoclonal antibodies used to select clonotypic antigen‐specific cytotoxic T cells , 1985, European journal of immunology.
[26] R. North. Down-regulation of the antitumor immune response. , 1985, Advances in cancer research.
[27] D. Naor. Suppressor cells: permitters and promoters of malignancy? , 1979, Advances in cancer research.